Head and neck cancer
A study comparing 2 chemotherapy regimens, Paclitaxel-Carboplatin versus Paclitaxel-Carboplatin plus metronomic chemotherapy in advanced Head and neck cancer
Who can joinAsk the trial team
AgeAsk the trial team
Kind of studyPhase 4: after approval
What it testsA medicine
The full list of who can and cannot join is on the registry. Ask the trial team, or write to us and we will explain it in simple words.
Last updated on the registry 15 Sep 2025. Please confirm with the hospital that this trial is still taking patients.
Contact hospital
The registry names this hospital as the trial's main contact. Ask them which hospitals are taking patients.
Cancer Research and Statistics FoundationIndiaDirections ↗
Registry summary (technical)
Phase 4 trial evaluating the 2 standard palliative chemotherapy regimens of PC (Paclitaxel+Carboplatin) versus PCm (PC+Oral Metronomic) in advanced Head and neck cancer - PHOENIX
Sponsor: Cancer Research and Statistic Foundation CRSF
CTRI/2023/02/049962 on CTRI, India's trial registry
Source: Clinical Trials Registry – India (CTRI), via WHO ICTRP, data of 12 Oct 2026
Last updated on the registry 15 Sep 2025 · read by us 5 Nov 2026